Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of oncology therapies... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIMOX | 18.04 | 0.04 | +0.22% |
| AQR International Momentum Style I | |||
| ACFNX | 79.64 | N/A | N/A |
| American Century Focused Dynamic Gr R6 | |||
| JHURX | 35.32 | N/A | N/A |
| JPMorgan Emerging Markets Equity R3 | |||
| HLFNX | 34.70 | N/A | N/A |
| Hennessy Large Cap Financial Investor | |||
| MLVKX | 31.02 | N/A | N/A |
| BlackRock Advantage Large Cap Val K | |||
A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.
| Ticker / NAME | Correlation To JBPHF | 1D Price Change % | ||
|---|---|---|---|---|
| JBPHF | 100% | N/A | ||
| RAPT - JBPHF | 79% Closely correlated | +4.36% | ||
| AXSM - JBPHF | 32% Poorly correlated | +0.43% | ||
| PYPD - JBPHF | 23% Poorly correlated | +0.58% | ||
| LXRX - JBPHF | 21% Poorly correlated | +5.08% | ||
| TNYA - JBPHF | 20% Poorly correlated | +22.51% | ||
More | ||||